Información del artículo
El Texto completo está disponible en PDF
Bibliografía General
[1.]
R. Peto, A.D. López, J. Boreham, M. Thun, C. Heath.
Mortality from developed countries; indirect estimation from national vital stadistics.
Lancet, 339 (1992), pp. 1268-1278
[2.]
R. Peto, A.D. López, J. Boreham, C. Heath.
Mortality from smoking in developed countries. 1950-2000.
[3.]
Estudio de los estilos de vida de la población adulta española..
[4.]
T.P. Houston.
The role of organized medicine and the American Medical Association in Tobacco Control.
MCMJ, 56 (1995), pp. 20-22
[5.]
C.B. Taylor, J.D. Killen.
Why do you smoke? The facts about smoking. USA 1991.
pp. 25-40
[6.]
J.F. Golding.
Smoking.
Resp Med, 4 (1990), pp. 445-460
[7.]
N.L. Benowitz.
The genetics of drug dependence: tobacco addiction.
N Engl J Med, 327 (1992), pp. 881-883
[8.]
L. Sánchez Agudo.
El tabaquismo un problema de Salud Pública.
[9.]
J.M. González de Vega, A. Romero Ortiz.
Factores inductores a la iniciación al tabaco.
Aproximación al tabaquismo en España, Nicorette,, pp. 42-43
[10.]
U.S. Department of Health and Human Services..
Public Health Service. The health consequences of smoking, nicotine addiction. A report of Surgeon General.
[11.]
L. Sánchez Agudo.
La prevención de la EPOC. Campañas y programas de control del tabaquismo. Enfermedad pulmonar obstructiva crónica (Programa Pneumobil).
pp. 50-72
[12.]
V. Sobradillo Peña, J.I. Bomenechea Benguria.
Patología relacionada con el tabaco. Aproximación al tabaquismo en España.
pp. 67-79
[13.]
J. Prochazka, C.C. Diclemente.
Stages and processes of self change of smoking: toward an integrative model of change. J.
Consult Clin Phychology, 51 (1983), pp. 395-406
[14.]
J. Prochazka, C.C. Diclemente, W. Velicer.
Predicting change in smoking status for self changers.
Addict Behav, 10 (1985), pp. 395-406
[15.]
J. Prochazka, C.C. Diclemente.
Stages of change in the modification of problems behaviours.
Progress in behaviours modification,
[16.]
Prochazka J, Velicer W, Diclemente C. Patters of change: dynamic typology applied to smoking cessation. Multivariate Behar Res (en prensa).
[17.]
C.A. Jiménez Ruiz, F. Barrueco Ferrero, R. Carrión Valero, I. Cordovilla, E. Hernández, O. Martínez Moragon, et al.
Intervención mínima personalizada en el tratamiento del tabaquismo. Resultados de un estudio multicéntrico.
Arch Bronconeumol, 34 (1998), pp. 41-44
[18.]
P. Plans, E. Navas, G. Rodríguez, N. Gali, R. Gaytar.
Coste-efectividad de los métodos de cesación tabáquica.
Med Clin (Barc), 104 (1995), pp. 49-53
[19.]
S.R. Cummings, S.M. Rubin, F. Oster.
The cost-effectiveness of counseling smokers to quit.
JAMA, 261 (1989), pp. 75-79
[20.]
K. Slam, S. Karsenly, A. Hirsch.
Effectiveness of minimal intervention by general practitioners with their smoking patientes: a randomized, controlled trial in France.
Tobacco Control, 4 (1995), pp. 162-169
[21.]
US Department of Health and Human Services.
Preventing Tobacco among young people. A report of the Surgeon General. Atlanta (USDHH): Public Health Services. Centers of Disease Control and Prevention. Centers of Chronic Disease Prevention and Health Promotion.
Office on Smoking and Health,, (1994),
[22.]
C.A. Jiménez Ruiz, J.M. González de Vega, C. Escudero Bueno, J. García Hidalgo, J. Roca Torrent, S. Solano Reina.
Manuales SEPAR. Tabaquismo (vol 1), (1995), pp. 1-109
[23.]
M. Schneider.
Nicotine therapy in smoking cessation. Pharmacokinetic considerations.
Clin Pharmacokinetic, 23 (1992), pp. 169-172
[24.]
C.A. Jiménez Ruiz.
Terapia sustitutiva con nicotina. Aspectos práctico.
Rev Clin Esp, 198 (1998), pp. 181-185
[25.]
M.A.H. Russell, M. Raw, M. Jarvis.
Clinical use of nicotine chewing gum.
Br Med J, 28 (1980), pp. 1599-1602
[26.]
C.A. Jiménez Ruiz, S. Solano Reina, J.M. González, M.J. Ruiz, S. Flórez, A. Ramos, et al.
Normativa sobre el Tratamiento del Tabaquismo de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Arch Bronconeumol, (1999), pp. 499-506
[27.]
P. Tonnessen, V. Fryd, M. Henisen.
Effect of nicotine chewing gum in combination with group counseling in the cessation of smoking.
N Engl J Med, 318 (1988), pp. 15-18
[28.]
M. Schneider, R. Olmstead, F. Mody.
Efficacy of a nicotine nasal spray on smoking cessation: a placebo controlled double-blind trial.
Addiction, 90 (1995), pp. 1671-1682
[29.]
A. Hjalmarsson, M. Franzon, A. Westin, O. Wiklund.
Effect of nicotine nasal spray on smoking cessation: a randomised, placebo controlled double-blind study.
Arch Inter Med, 154 (1994), pp. 2567-2572
[30.]
E. Lunell, L. Molander, S. Leischow, K. Fagerström.
Effect of nicotine vapour inhalation on the relief of tobacco with-drawal symptoms.
Eur J Clin Pharmacol, 48 (1995), pp. 235-240
[31.]
KO. Fagerström.
Combined use of nicotine replacement products.
Health Values, 18 (1994), pp. 15-20
[32.]
C.A. Jiménez Ruiz, S. Solano Reina.
Tratamiento del tabaquismo. Terapia sustitutiva con nicotina.
Rev Clin Esp, 194 (1994), pp. 487-490
[33.]
M. Kornitzer, M. Bentsen, X.M. Dramai, J. Thijs.
Patch and gum in smoking cessation: a placebo controlled clinical trial.
Prevent Med, 24 (1995), pp. 41-47
[34.]
E. Gritz.
Cigarrette smoking: the need for action by health professionals.
CA, 38 (1998), pp. 194-212
[35.]
A. Bohadama, F. Nilsson, Y. Martinet.
Nicotine inhaler and nicotine patch: a combination therapy for smoking cessation a randomized double-blind placebo controlled trial.
[36.]
A. Batra, P. Schupp, G. Buchkremer.
Combined used of nicotine replacement products in highly dependent smokers. Effectiveness of nasal spray and patch.
[37.]
D.E. Josenby, S.J. Leischow, M.A. Nides, S.I. Reunard, J.A. Johnston, A.R. Hughes, et al.
A controlled trial of sustaine release bupropion, a nicotine patch or both for smoking cessation.
N Engl J Med, 340 (1999), pp. 685-691
[38.]
L. Dale, R. Hurt, K. Offord, G. Lawson, I. Croghan, D. Schroeder.
High dose nicotine patch therapy percentage of replacement and smoking cessation.
JAMA, 274 (1995), pp. 1353-1358
[39.]
J.A. Ascher, J.O. Cole, J.N. Colin.
Bupropion: a review of its mechanism of antidepressant activity.
J Clin Psychiatry, 56 (1995), pp. 395-401
[40.]
B.R. Cooper, C.M. Wang, R.F. Cox, R. Norton, V. Shea, R.M. Ferris.
Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.
Neuropsychopharmacology, 11 (1994), pp. 133-141
[41.]
Glaxo Wellcome.
Zyban® Product Monograph.
Ontario (Canadá),, (1998),
[42.]
S. Solano Reina, C.A. Jiménez Ruiz.
Mecanismos de iniciacioón al tabaco. Dependecia no farmacológica.
Arch Bronconeumol, 31 (1995), pp. 109-113
[43.]
H. Pardell, E. Saltó, L.L. Salleras.
editores. Manual de diagnóstico y tratamiento del tabaquismo.
pp. 157-171
[44.]
L. Sánchez Agudo.
Tratamiento especializado del tabaquismo.
Arch Bronconeumol, 31 (1995), pp. 124-132
[45.]
American Psychiatric Association.
Directrices para la práctica clínica en el tratamiento de pacientes con dependencia de nicotina (ed. española).
[46.]
E. Becoña Iglesia, F.L. Vázquez González.
Dejar de fumar como un proceso: implicaciones asistenciales. Libro blanco sobre el tabaquismo en España.
pp. 227-252
[47.]
G. Marlatt, J. Gordon.
Relapse pevention: maintenance strategies in the treatment of adictive behaviours.
[48.]
US Public Health Service.
The health benefits of smokink cessation.
A report of the Surgeon General Washington DC: Department of Health and Human Services, (1990), pp. 90-8416
[49.]
R.C. Klesges, A.W. Myers, L.M. Lesges, M.E. La Vasque.
Smoking body weight and effects on smoking behavior: a comprehensive review of the literature.
Psychol Bull, 106 (1989), pp. 402-430
[50.]
J. Rodin.
Weight change following smoking cessation: the role of food intake an exercise.
Addict Behav, 12 (1987), pp. 303-317
[51.]
N.E. Grunberg, D.J. Bowen, V.A. Maycock, S.M. Nespor.
The importance of sweet taste and caloric content in the effects of nicotine on specific food consumption.
Psychopharmacology, 12 (1985), pp. 198-203
[52.]
S. Alonso Viteri, O. Perelló Bosch, C. Cisneros, C. Almonacid Sánchez, S. Solano Reina, J.L. Álvarez-Sala, et al.
Actualizaciones sobre el tratamiento del tabaquismo: otros tratamientos.
Madrid: Documentos Técnicos de Salud Pública, (1999), pp. 95-102
[53.]
H.J. Eysenck.
The causes and effects of smoking.
[54.]
M. Barrueco, M. Vicente, I. López, T. Gonsalves, D. Terrero, J. García, et al.
Tabaquismo escolar en el medio rural de Castilla-León. Actitudes de la población escolar.
Arch Bronconeumol, 31 (1995), pp. 2327
[55.]
M. Barrueco, M. Vicente, J.L. Garavís, J. García, M.C. Rodríguez.
Prevención del tabaquismo en la escuela: resultados de un programa realizado durante 3 años.
Arch Bronconeumol, 34 (1998), pp. 323-328
[56.]
D. Marín Tuyá.
Tabaco y adolescentes: más vale prevenir.
Med Clin (Barc), 100 (1993), pp. 497-500
[57.]
A. Martínez Hamas.
Patología del consumo del tabaco.
Copyright © 2000. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
